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A B S T R A C T
Nʹ-Nitrosonornicotine (NNN), a carcinogenic tobacco-specific Nʹ-nitrosamine (TSNA), is on the FDA list of harmful
and potentially harmful constituents (HPHCs). Nornicotine, a product of the demethylation of nicotine, is the
immediate alkaloid precursor for NNN formation. Nicotine, nornicotine and NNN are optically active. The
accumulation of the isomers of nicotine, nornicotine, and NNN impacts their biological activity. In this paper, we
report the determination of tobacco alkaloid enantiomers (including nicotine, nornicotine, anabasine, and ana-
tabine) in samples of different tobacco lines using a reversed phase ultra-performance liquid chromatography-
tandem mass spectrometer (UPLC/MS/MS) method. Current method demonstates excellent detection capability
for all alkaloid enantiomers, with correlation coefficients (r2) > 0.996 within their linear dynamic ranges. The
limit of detection (LOD) and limit of quantitation (LOQ) of all analytes are less than 10 ng/mL and 30 ng/mL,
respectively. In addition, their recovery and coefficient of variation (CV%) are within 100–115% and 0.2–3.7%,
respectively. The method validated in this paper is simple, fast, and sensitive for the quantification of alkaloid
enantiomers in tobacco leaf and has been applied to investigations of tobacco alkaloid enantiomer ratios in
different tobacco lines and tobacco products.
1. Introduction
Smoking damages many body organs and causes diseases to smokers.
Cigarette smoking is the leading preventable cause of death in the United
States. Worldwide, smoking causes approximately 7 million deaths each
year [1]. In June 2009, the law authorized U.S. Food and Drug Admin-
istration (FDA) to regulate the manufacture, marketing, and distribution
of tobacco and tobacco products. In March 2012, FDA established a list of
harmful and potentially harmful constituents (HPHCs) in tobacco prod-
ucts and tobacco smoke [2]. Nʹ-Nitrosonornicotine (NNN) is listed as a
carcinogenic compound on the FDA HPHCs list. Nornicotine, the result of
nicotine demethylation, is the immediate alkaloid precursor for NNN
formation. Both nicotine and nornicotine exist as (R)- and (S)- enantio-
meric isoforms that differ at the 20-C position of the pyrrolidine ring
(Fig. 1). The different alkaloid enantiomers have different pharmaco-
logical activities. It has been reported that (S)-nicotine is more pharma-
cologically potent than (R)-nicotine [3, 4] while (S)-NNN is more
carcinogenic than the (R)-isoform [5]. Although (R)-nicotine shares
many physicochemical properties with (S)-nicotine, it has been found
that (S)-nicotine has a greater level of toxicity. LD50s for intravenous
administration of (R)-nicotine in several species of animals have been
approximately 18 times higher than that of (S)-nicotine [4].
The carcinogenicity of (S)-NNN has been postulated to be greater than
(R)-NNN in rat esophagus [6, 7], and this was confirmed by a recent rat
feeding assay [5]. Since nornicotine is the major metabolite of nicotine
and the precursor of NNN, and it has been verified that (S)-NNN is pro-
duced only from (S)-nornicotine [8], we may reduce the harmful effects
of cigarettes by adjusting the enantiomeric ratio of nornicotine, and
hence the enantiomeric ratio of NNN. More of the (R) form would be
desirable. The enantiomeric composition of NNN is dependent on the
enantiomeric composition of its alkaloid precursor, nornicotine [8].
Quantitative analysis of the enantiomers of nicotine, nornicotine, and
NNN is crucial to understand the metabolomic mechanism and compo-
sitional changes in the enantiomers of nicotine and nornicotine, and thus
the enantiomer composition changes of NNN and potentially its biolog-
ical activity.
A few papers have reported the determination of alkaloid enantio-
mers in tobacco. Alkaloid enantiomer analyses have been performed
using normal phase high-performance liquid chromatography (HPLC)
coupled with a diode-array or UV detector, multi-dimensional gas
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chromatography with mass spectrometry, or combined HPLC-UV detec-
tor and GC/MS [9, 10, 11, 12, 13]. However, these methods have limi-
tations for routine analysis. The GCmethod involves the derivatization of
alkaloids and has a long analysis time. Normal phase HPLC uses toxic and
strong organic solvents, thereby requiring instrumentation to have
greater tolerance for organic solvents. In this paper, a novel
reverse-phase UPLC/MS/MS method for determination of alkaloid en-
antiomers in tobacco is presented. The advantages of this method include
simple sample preparation with the extraction of alkaloids using meth-
anol and water, running HPLC analysis with regular mobile phases, as
well as higher sensitivity comparing with existing methods. This method
has been successfully applied to alkaloid enantiomers analysis in
different tobacco lines and tobacco products.
2. Experimental
2.1. Samples
Reference ground tobacco products (burley, flue-cured, oriental, dark
fire-cured, and dark air-cured tobacco leaf) were purchased from the
Center for Tobacco Reference Products (University of Kentucky, KY).
CORESTA smokeless tobacco reference products were obtained from
North Carolina State University, Raleigh, NC. Plants of different tobacco
lines were grown at the University of Kentucky Agricultural Spindletop
Farm. Lines included (1) a high nicotine demethylation line of TN90, (2)
low nicotine demethylation lines of TN86 and TN90, and (3) double and
triple mutant lines of TN86 and TN90 for decreased nicotine demethy-
lation. The triple mutant lines carry knockouts of genes CYP82E4,
CYP82E5, and CYP82E10 for nicotine demethylation and the double
mutant line carries knockouts of CYP82E4 and CYP82E5 [8]. The
transgenic plants were RNAi knockouts of all nicotine dementylation
genes in the TN90 line [14]. All tobacco plants were harvested and
air-cured in a traditional air-curing barn. After curing, the fourth leaf
from the top of each plant was removed, the lamina and midrib were
separated, and then five leaves from different plants were combined,
freeze-dried, and ground as one sample. There were four replicates for
each sample.
2.2. Reagents and materials
The alkaloid analytical standards (racemic R, S-nicotine (purity
99%), racemic R, S-nornicotine (purity 98%), and racemic R, S-
anabasine (purity 97%)), and ammonium formate (LC/MS grade,
putrity 99.0%) were purchased from Sigma-Aldrich Corporation (St.
Louis., MO). Racemic R, S-anatabine (purity 97%) was from Matrix
Scientific (Columbia, SC). (R)-nicotine (purity 98%), (S)-nornicotine
(purity 96%), and isotopically labeled racemic R, S-nicotine-d4
(purity 98%) were obtained from Toronto Research Chemicals
(Toronto, Canada). Labeled racemic R, S-nornicotine-d4 (purity
98%) was from CDN Isotopes Inc. (Quebec, Canada). Nicotine-d4
and nornicotine-d4 isomers were used for internal standards. LC/MS
grade acetonitrile and methanol were from Fisher Scientific (Hamp-
ton, NH). Tomato leaf (NIST 1573a) standard reference material was
purchased from the National Institute for Standards and Technology
(NIST) (Gaithersburg, MD). The tomato leaves were used as the matrix
during the experiment because tomato and tobacco are members of
the same plant family, Solanaceae [15], but tomato leaves do not
contain detectable levels of tobacco alkaloids.
2.3. Instrumentation and apparatus
All analyses were done on a Waters ACQUITY UPLC H-Class Sys-
tem equipped with Xevo TQD Triple Quadrupole Mass Spectrometry
(Waters Corporation; Milford, MA). The CHIRALPAK AGP column
(150  4 mm column with 5 μm particle size) and LUX-Cellulose-2
column (150  2 mm column with 3 μm particle size) were used for
nicotine and nornicotine enantiomer analysis, respectively. The en-
antiomers of anabasine and anatabine can be separated on both col-
umns. Only the CHIRALPAK AGP column was used for analysis of
anabasine and anatabine enantiomers in this paper. Separation of the
enantiomers of nicotine, anabasine, and anatabine was achieved using
an isocratic mobile phase program consisting of 90:10 (v/v) of 30 mM
ammonium formate with 0.3% NH4OH and methanol with a flow of
0.4 mL/min (Fig. 2). For nornicotine enantiomer separation, an iso-
cratic program of 90:10 (v/v) of 20 mM ammonium formate with
0.2% NH4OH:acetonitrile was used, and the flow rate was 0.2 mL/min
(Fig. 2). The Waters Xevo TQD was operated in the electrospray
ionization (ESI) in the positive mode with Multiple Reaction Moni-
toring (MRM) (Table 1). Source and desolvation temperatures were
150 and 500 C, respectively. The desolvation gas flow was 800 L/hr.
The capillary voltage was 0.38 kV.
2.4. Sample preparation and analysis procedure
Tobacco plant samples were freeze-dried and ground to pass
through a 1 mm screen and mixed well to ensure homogeneity. 200
mg of ground tobacco samples were placed in 20 mL glass vials. Iso-
topes of racemic R, S nicotine-d4 and racemic R, S-nornicotine-d4 as
internal standards were spiked into the same vial prior to the addition
of 200 μL of 5N NaOH pre-treatment solution, and the samples were
allowed to stand for 10 minutes. After that, 10 mL 70% methanol was
added and the mixture was placed on a horizontal shaker to shake for
Fig. 1. Structures of tobacco alkaloid enantiomers.
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one hour. The extracts were filtered through a 0.22 μm PTFE filter to
remove the tobacco powder and then diluted 20-fold with 70%
methanol for alkaloid measurement. A 2 μL aliquot of the filtered
extract solution was injected into the UPLC/MS/MS to determine the
alkaloid enantiomers in each tobacco sample. For each tobacco sam-
ple, only one extraction needs to be done, but two injections onto the
appropriate column were required to obtain the enantiomer results for
all of the alkaloids.
3. Results and discussion
3.1. Column selection
There are many types of chiral columns on the market at present. The
first step in method development was column screening. The CHIR-
ALPAK AGP and CBH columns, LUX Cellulose-1, LUX Cellulose-2, LUX
Cellulose-3, LUX Cellulose-4 and LUX Cellulose-5 columns were tested.
Table 1
Mass spectrometric parameters for the quantification and confirmation of alkaloids in the multiple reaction monitoring (MRM) mode.
Compound Quantitation Transition (m/z) Collision (V) Confirmation Transition (m/z) Collision (V)
(R)-Nicotine 163 > 132 16 163 > 117 26
(S)-Nicotine 163 > 80 14 163 > 117 26
(R,S)-Nicotine-d4 167 > 136 14 167 > 121 24
(R,S)-Nornicotine 149 > 117 20 149 > 80 18
(R,S)-Nornicotine-d4 153 > 121 22 153 > 96 24
(R,S)-Anabasine 163 > 92 20 163 > 80 18
(R,S)-Anatabine 161 > 107 12 161 > 80 28
Fig. 2. Separation of nicotine, anatabine, and anabasine enantiomers from racemic alkaloid standards on the CHIRALPAK AGP column (A). R-nicotine and S-anatabine
were distinguished and quantified by the differences in quantitation and confirmation transitions (m/z) for each (see Table 1). Separation of nornicotine enantiomers
from the racemic nornicotine standard on the LUX Cellulose-2 column (B).
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Preliminary results indicated that the enantiomers of nicotine, anabasine,
and anatabine had full baseline separation when the CHIRALPAK AGP
column was used. However, the enantiomers of nornicotine only reached
85% baseline separation with this column. To obtain high resolution
separation of nornicotine isomers, the LUX Cellulose-2 column was used
(Fig. 2). Both columns separated anatabine and anabasine enantiomers
very well, the resolution value is greater than 1.5.
3.2. Optimization of mobile phase
Different buffer solutions, including ammonium acetate, ammonium
bicarbonate, and ammonium formate, were investigated for an appro-
priate mobile phase. The optimum result was achieved with ammonium
formate. It was found that the pH value was critical for separation of the
alkaloid enantiomers (data not shown). pH affects peak separation as
well as the retention time. Ammonium hydroxide was used to adjust the
pH to 9.5 for alkaloid enantiomer separation. Different organic solvents,
such as acetonitrile, methanol, 2-propanal, and t-butanol were tested as
mobile phase modifiers to improve the enantiomer separation. Our re-
sults indicate that methanol and acetonitrile are good mobile phase
modifiers for the separation of nicotine and nornicotine enantiomers,
respectively.
3.3. Optimization of extraction method
To optimize the extraction of alkaloids from ground tobacco leaf, the
samples were extracted by shaking for one hour in different percentages
of methanol and water. Mixtures consisting of 100%, 90%, 80%, 70%,
50%, and 0% methanol in water were evaluated. Five replicates were
performed for each condition. The 70% and 50% methanol/water mix-
tures were found to have similar extraction efficiency for all target
analytes. The S-nicotine extraction efficiency as an example was shown in
Fig. 3. However, 50% methanol, which has greater water content, is
capable of removing more salt from the tobacco samples and could
potentially cause salt precipitation issues later. Therefore, 70%methanol
was chosen as the extraction solution in these studies.
Fig. 3. Extraction efficiency of S-nicotine from ground tobacc in different concentrations of methanol (n ¼ 5). Data were normalized to 70% MeOH extraction.
Table 2
Summary of the limits of detection (LODs), the limits of quantitation (LOQs), and calibration curve range/linearity (n ¼ 5).
LOD (ng/mL) LOQ (ng/mL) Calibration Range (ng/mL) Slope (average) Intercept (average) Linearity, R2 (average)
(R)-nicotine 8.4 28 100–4200 1.0651 -5.8554 0.9987
(S)-nicotine 5.4 18 350–14000 0.1437 -4.2977 0.9982
(R)-nornicotine 6.0 20 50–2100 1.1244 -5.3211 0.9988
(S)-nornicotine 6.0 20 50–2100 1.1177 -5.6773 0.9988
(R)-anatabine 4.8 16 50–2110 0.5545 -1.1916 0.9967
(S)-anatabine 5.7 19 50–2110 0.5630 -3.0739 0.9975
(R)-anabasine 1.2 4 15–530 0.8571 -0.8130 0.9984
(S)-anabasine 4.2 14 15–530 0.8223 0.3679 0.9991
Table 3
Method accuracy with spiked alkaloids into the tomato leaf matrix (n ¼ 3).
Analyte Spiked Concentration Recovery CV
(ng/mL) % %
(R)-nicotine 944.6 104.6 2.4
1889.2 107.4 1.3
3778.4 103.9 0.5
(S)-nicotine 944.6 108.8 3.3
1889.2 106.2 0.7
3778.4 104.9 1.9
(R)-nornicotine 428.8 114.5 3.7
857.6 115.7 0.2
1715.2 113.2 2.6
(S)-nornicotine 428.8 112.8 2.0
857.6 113.4 1.1
1715.2 109.0 1.1
(R)-anatabine 422.0 103.4 2.9
844.0 104.8 1.4
1688.0 102.7 0.4
(S)-anatabine 422.0 102.6 1.7
844.0 103.4 1.3
1688.0 101.9 0.7
(R)-anabasine 213.6 101.4 3.6
427.2 104.0 1.0
854.4 102.9 1.8
(S)-anabasine 213.6 107.2 3.5
427.2 108.9 1.0
854.4 107.3 1.8
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3.4. Method validation
The standard calibration curves of the alkaloid enantiomers were
established by injecting a series of individual alkaloid enantiomer stan-
dard solutions of known concentrations into the UPLC/MS/MS. The
standard calibration solutions of these alkaloid enantiomers were made
by spiking a known amount of alkaloid enantiomers and internal stan-
dards (isotope racemic R, S nicotine-d4 and racemic R, S nornicotine-d4)
in the tomato leaf matrix before following the sample extraction pro-
cedure mentioned above in the Experimental Section. A 2 μL aliquot of
each filtered extract solution was injected into the UPLC/MS/MS. Mas-
slynx software was used to collect and process the data. The ratios of the
peak area of each enantiomer to their corresponding internal standard
were calculated. The graphs of the peak area ratio versus the concen-
tration ratio of each alkaloid to its appropriate internal standard were
plotted. The calibration type is linear with 1/x weighting, and the
regression lines are not forced through the origin. All alkaloid enantio-
mers showed an excellent linear response (>0.996) (Table 2).
The method was validated for precision and accuracy of each ana-
lyte at different concentrations. The low, medium, and high levels of
the alkaloid isomers with internal standards were spiked onto the to-
mato leaf matrixes. Three replicates of each concentration level were
tested. The blank tomato leaf with internal standards only was used as
the control. The recovery and coefficient of variation (CV%) of each
enantiomer in the extraction procedure was 100–115% and 0.2–3.7%,
respectively (Table 3), which indicates that our method has good ac-
curacy and precision. The limit of detection (LOD) and the limit of
quantitation (LOQ) were estimated by injecting a series of known-
concentration alkaloid enantiomer standards into the UPLC/MS/MS 5
times. The standard deviations of the concentration from the five in-
jections versus the concentration of each alkaloid were plotted. The
value of the y-intercept of a linear regression (s0) is the estimation of
standard deviation when the analyte is zero. The LOD and LOQ were
estimated as 3s0 and 10s0, respectively [16]. The LOD and LOQ results
are presented in Table 2.
3.5. Detection of enantiomers in tobacco leaf and tobacco products with
current method
TSNAs are carcinogenic compounds present in tobacco leaf, and (S)-
NNN has more toxicity than (R)-NNN [5]. In order to reduce the harmful
effects of cigarette smoking, scientists have recently expended consid-
erable effort to change the accumulation of nornicotine, the precursor of
NNN, especially in burley tobacco. These efforts include the screening of
parental seed source plants, the release of low nicotine demethylation
(LC seed) varieties [17], and GMO tobacco lines [8]. Depending on the
tobacco line, the percentage of R-nornicotine in total nornicotine varies
from 4 to 75% [18]. Alkaloid enantiomer analysis can help elucidate the
composition of these enantiomers in tobacco. Our reverse phase
UPLC/MS/MSmethod has been used to identify and quantify the alkaloid
enantiomers in different tobacco lines including low nicotine demethy-
lation (low conversion, LC) and high nicotine demethylation tobacco
samples, as well as double- and triple-gene mutants for lower nicotine
demethylation, and RNAi transgenic plants. In these samples, the triple
mutant and the RNAi transgenic tobacco samples have ultra-low levels of
nicotine demethylation. Results from ultra-low nicotine demethylation
tobaccos indicate that the ratio of nornicotine isomers is altered in the
leaf. The ultra-low nicotine demethylation activity decreased the per-
centage of (R)-nornicotine in the leaf (Table 4). This is consistent with the
previous results of Cai and Bush (2012) [18]. Our method was also used
to measure the enantiomers of tobacco alkaloids in different kinds of
tobacco samples, such as cigar filler, reference cigarette filler, CORESTA
smokeless tobacco reference products, as well as different tobaccomarket
types, including burley, oriental, dark air-cured, dark fire-cured, and
flue-cured. Our results are consistent with other published data [10, 11,
12]. In these tobacco samples, the major enantiomer of nicotine is
(S)-nicotine (>99%) and most of them have a higher percentage of
(S)-nornicotine than (R)-nornicotine. The range of the percentage of
(R)-nornicotine was 15–50%. The ratio of (R)- and (S)-anabasine was
consistent in the different tobacco samples, and the levels of (S) anaba-
sine were slightly higher than R-anabasine. The percentage of
Table 4
Percentage of R-alkaloids and demethylation of nicotine in the different tobacco lines (n ¼ 4).
Sample Type Nicotine Nornicotine Anatabine Anabasine Nicotine
R/total R/total R/total R/total Demethylation
% % % % %
TN90 transgenic 4.11 16.93 9.13 33.95 0.58
triple mutant 3.81 17.20 9.57 40.08 0.57
double mutant 0.32 75.89 10.15 42.40 2.02
Low Conversion 0.09 57.86 9.35 40.37 2.43
TN86 triple mutant 4.32 15.02 9.88 40.19 0.66
Low Conversion 0.11 53.72 10.28 42.78 2.61
TN90 High Conversion 0.11 7.21 10.69 48.63 38.84
Table 5
Percentage of R-alkaloids found in individual tobacco types, cigarette and cigar filler, and smokeless reference products (n ¼ 3).
Sample Type Nicotine Nornicotine Anatabine Anabasine
R/total R/total R/total R/total
% % % %
Tobacco leaf RT2 (flue cured) 0.10 33.22 15.13 37.74
RT3 (oriental) 0.38 14.94 15.72 41.97
RT4 (Burley) 0.07 32.41 13.84 37.58
RTDAC (dark air) 0.06 48.75 13.28 40.05
RTDFC (dark fire) 0.40 40.14 13.42 40.76
Filler RT6 (cigar filler) 0.27 16.24 13.43 38.67
RT1 (1R6F filler) 0.13 30.32 14.65 38.60
Smokeless tobacco CRP1.1 (Snus) 0.32 31.42 15.57 42.75
CRP2.1 (Moist Snuff) 0.40 25.97 15.08 41.99
CRP3.1 (Dry Snuff) 0.44 25.91 14.37 39.68
CRP4.1 (Loose- leaf Chewing) 0.21 17.53 13.72 41.19
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(R)-anatabine was also consistent in the different tobacoo samples,
approximately 15% (Table 5).
4. Conclusions
We have developed and validated a simple, rapid, and sensitive
UPLC/MS/MS method for the quantification of alkaloid enantiomers in
tobacco samples. This reverse phase LC/MS/MS method has been suc-
cessfully applied to the determination of tobacco alkaloid enantiomers in
tobacco leaves as well as a wide range of tobacco products.
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